Poster Abstract Session:
225. Antibiotic Stewardship: Pediatrics
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:


Tracks: Pediatric ID, Epidemiology and Infection Control

Accuracy of Administrative Data in Comparison to Administered Antimicrobial Doses for Hospitalized Children
Sarah Parker, MD ; Joshua Courter, PharmD ; Cary Thurm, PhD ; Matthew Kronman, MD, MSCE ; Scott Weissman, MD ; Samir Shah, MD, MSCE ; Adam L. Hersh, MD, PhD ; Thomas Brogan, MD ; Sameer Patel, MD, MPH ; Michael Smith, MD ; Brian Lee, MPH, PhD ; Jason Newland, MD, MEd, FPIDS ; Jeffrey S. Gerber, MD, PhD
Implementation of an Antibiotic Stewardship Program Optimizes Clinical Outcomes in Pediatric Care
Erin O'donnell, MD ; Heidi Andersen, MD ; Joshua Courter, PharmD ; Stuart Goldstein, MD ; Lilliam Ambroggio, PhD, MPH ; David Haslam, MD
Antibiotic prescribing in the pediatric Kentucky Medicaid population
Michael Smith, MD ; Navjyot Vidwan, MD ; Yana Feygin, MS ; John Myers, PhD ; Charles Woods, MD, MS, FIDSA, FSHEA, FPIDS
  • SMITH 10.25.16.pdf (527.2 kB)
  • Antimicrobial Stewardship in the NICU: Building and Sustaining the effective Collaboration
    Kanokporn Mongkolrattanothai, MD ; Steven Chin, MD ; Nair Srikumar, MD ; Ting-Yi Lin, MD ; Jenna Holmen, MD ; Matthew Gentry, pharmD ; Michael Luu, MPH
    Antibiotic Use for Children with Pneumonia: Sustained Adoption of National Guidelines at US Children’s Hospitals
    Derek J. Williams, MD, MPH ; Matthew Hall, PhD ; Jeffrey S. Gerber, MD, PhD ; Mark Neuman, MD ; Adam L. Hersh, MD, PhD ; Thomas Brogan, MD ; Kavita Parikh, MD ; Sanjay Mahant, MD ; Anne J. Blaschke, MD, PhD, FIDSA, FPIDS ; Samir Shah, MD, MSCE ; Carlos G. Grijalva, MD, MPH
    Trend in Resistant Gram Negative Organisms in Children: Role of an Antimicrobial Stewardship Program
    John Lyles, MD ; Benjamin Hammer, PharmD ; Victoria Basalyga, PharmD, BCPS ; Bryan Stierman, MD, MPH ; Joseph Campos, PhD ; Nalini Singh, MD, MPH, FIDSA, FSHEA, FPIDS
    Successful Reduction in Medication Use in RSV Bronchiolitis by Repeated PDSA Cycles
    Asif Noor, M.D. ; Leonard R. Krilov, MD ; Andre Rebaza, MD ; Lyn Quintos, M.D.
  • 1918_IDWPOSTER.pdf (712.5 kB)
  • Budget Impact Analysis of Ceftriaxone Dosing Regimens for Urinary Tract Infections in a Pediatric Hospital 
    Wassim Ballan, MD ; Cynthia Toy, PharmD ; Richard Engel, MD ; Millie Wisdom, PharmD

  • UTI Ceftriaxone Poster .pdf (239.8 kB)
  • Impact of Antimicrobial Stewardship Program Restrictions on Acyclovir Usage in a Children’s Hospital
    Karen Ravin, MD ; Lori Handy, MD ; Shannon Chan, PharmD ; Steven Kapfer, MBA
    Variability in Antifungal and Antiviral Use in Hospitalized Children
    Jennifer Goldman, MD, MS ; Rachael Ross, MPH ; Brian Lee, MPH, PhD ; Jason Newland, MD, MEd, FPIDS ; Adam L. Hersh, MD, PhD ; Matthew Kronman, MD, MSCE ; Jeffrey S. Gerber, MD, PhD
    DUE Diligence: Using Drug Use Evaluations of Ciprofloxacin and Meropenem to Identify Opportunities for Antimicrobial Stewardship at a Pediatric Tertiary Care Facility
    Jaime Mcdonald, PharmD ; Baldwin Toye, MD ; Chaohui Wang, Pharmacy Student ; Jessica Dunn, MD ; Jennifer Bowes, M Sc ; Annie Pouliot, PhD ; Nicole Le Saux, MD
    Evaluation of a pharmacy directed vancomycin and monitoring pilot program at an academic pediatric hospital
    Philip Lee, Pharm D. ; Carly Mason, Pharm D. ; Haniyyah Ahmad-Hossain, Pharm D. ; Ka Yi Lam, Pharm D. ; Ellen Germain, Pharm D. ; Iona Munjal, MD
    Optimizing Vancomycin Prescribing Through A Pharmacist Driven Monitoring Intervention At A Children’s Hospital
    Jared Olson, PharmD ; Chris Stockmann, PhD, MSc ; Adam L. Hersh, MD, PhD ; Collin Anderson, PharmD PhD ; Jeffery Zobell, PharmD ; Emily Thorell, MD, MSCI
    Spaced education for antimicrobial stewardship effectively increases knowledge about duplicative anaerobic therapy
    Kelly B. Flett, MD, MMSc ; Athos Bousvaros, MD ; Patricia Martin, MPH ; Thomas J. Sandora, MD, MPH, FSHEA
    Antimicrobial Utilization in the Neonatal Intensive Care Unit (NICU): A Pressing Need for Stewardship
    Galit Holzmann-Pazgal, MD, FSHEA ; Amir Khan, M.D. ; Thomas Northrup, MD ; Christine Domonoske, PharmD ; Eric Eichenwald, MD
    Vancomycin-Associated Complications in Pediatric Outpatient Parenteral Antimicrobial Therapy
    Priyanka Fernandes, MBBS ; Kelly B. Flett, MD, MMSc ; Amanda Growdon, MD ; Fabienne Bourgeois, MD, MPH ; Helen Mahoney-West, MS, RN ; Catherine Lachenauer, MD ; Mari Nakamura, MD, MPH
  • OPATVanco_IDSA2016_Final.pdf (333.4 kB)
  • Utilizing Claims Data to Identify Stewardship Targets in Pediatrics
    Joshua Watson, MD ; Ling Wang, PhD, MPH ; Preeti Jaggi, MD
    Variability in Use and Total Expense of Inhaled Tobramycin for Hospitals Contributing to Pediatric Hospital Information Systems (PHIS)
    Sarah Parker, MD ; Cary Thurm, PhD ; Joshua Courter, PharmD ; Thomas Brogan, MD ; Adam L. Hersh, MD, PhD ; Jeffrey S. Gerber, MD, PhD ; Michael Smith, MD ; Sameer Patel, MD, MPH ; Matthew Kronman, MD, MSCE ; Samir Shah, MD, MSCE ; Brian Lee, MPH, PhD ; Jason Newland, MD, MEd, FPIDS
    Comparative effectiveness of intravenous versus oral antibiotics for post-discharge treatment of perforated appendicitis in children
    Lori Handy, MD ; Rana F. Hamdy, MD, MPH ; Matthew Bryan, PhD ; Daniele Dona, MD ; Evangelos Spyridakis, MD ; Areti Kyriakousi, PhD ; Talene A. Metjian, PharmD ; Jeffrey S. Gerber, MD, PhD
  • HandyAppendicitis_final.pdf (195.7 kB)
  • Antibiotic Therapy in Patients with Necrotizing Enterocolitis in the Neonatal Intensive Care Unit: A Quality Improvement Project
    Corey Lance, PharmD Candidate ; Shasha Bai, PhD ; Holly Maples, PharmD ; Mariam Khan, PharmD Candidate ; Nada Harik, MD ; Jingyun Li, MS ; Dawn Weiss, MD
    Effect of Antibiotic Duration Option Buttons in the Electronic Medical Record on Outpatient Antibiotic Prescribing in Pediatrics
    Marielle Fricchione, MD ; Hannah Palac, MS ; Daniel Healy, PharmD ; Rupal Patel, PharmD ; Larry Kociolek, MD ; Sameer Patel, MD, MPH

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.